Cargando…
Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073750/ https://www.ncbi.nlm.nih.gov/pubmed/35529785 http://dx.doi.org/10.21037/tlcr-21-1002 |
| _version_ | 1784701356010897408 |
|---|---|
| author | Dempke, Wolfram C. M. Fenchel, Klaus Reuther, Susanne Murphy, Michael F. |
| author_facet | Dempke, Wolfram C. M. Fenchel, Klaus Reuther, Susanne Murphy, Michael F. |
| author_sort | Dempke, Wolfram C. M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9073750 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90737502022-05-07 Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon? Dempke, Wolfram C. M. Fenchel, Klaus Reuther, Susanne Murphy, Michael F. Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2022-04 /pmc/articles/PMC9073750/ /pubmed/35529785 http://dx.doi.org/10.21037/tlcr-21-1002 Text en 2022 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Dempke, Wolfram C. M. Fenchel, Klaus Reuther, Susanne Murphy, Michael F. Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon? |
| title | Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon? |
| title_full | Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon? |
| title_fullStr | Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon? |
| title_full_unstemmed | Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon? |
| title_short | Durvalumab plus novel agents in non-small cell lung cancer—a new COAST on the horizon? |
| title_sort | durvalumab plus novel agents in non-small cell lung cancer—a new coast on the horizon? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073750/ https://www.ncbi.nlm.nih.gov/pubmed/35529785 http://dx.doi.org/10.21037/tlcr-21-1002 |
| work_keys_str_mv | AT dempkewolframcm durvalumabplusnovelagentsinnonsmallcelllungcanceranewcoastonthehorizon AT fenchelklaus durvalumabplusnovelagentsinnonsmallcelllungcanceranewcoastonthehorizon AT reuthersusanne durvalumabplusnovelagentsinnonsmallcelllungcanceranewcoastonthehorizon AT murphymichaelf durvalumabplusnovelagentsinnonsmallcelllungcanceranewcoastonthehorizon |